Wednesday, March 3, 2021  | 18 Rajab, 1442
Samaa TV
Facebook Twitter Youtube
X

vs

HOME > Health

Moderna vaccine gives 3 months immunity, firm plans 100m doses

Most of the doses will go to the US

SAMAA | - Posted: Dec 4, 2020 | Last Updated: 3 months ago
SAMAA |
Posted: Dec 4, 2020 | Last Updated: 3 months ago
Moderna vaccine gives 3 months immunity, firm plans 100m doses

Photo: AFP

Moderna plans to have 100 to 125 million doses of its COVID-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday.

Between 85 and 100 million of the doses will be distributed in the United States, with the rest of the world receiving the remaining 15 to 25 million, the Cambridge, Massachusetts-based company said in a statement.

Moderna also confirmed that it expects to have 20 million vaccine doses available in the US by the end of 2020.

The vaccine, which the company says was recently demonstrated to have 94% efficacy, causes the human immune system to produce potent antibodies that endure for at least three months, a study showed Thursday.

Researchers at the National Institute for Allergies and Infectious Diseases (NIAID), which co-developed the drug, studied the immune response of 34 adult participants, young and old, from the first stage of a clinical trial.

Writing in the New England Journal of Medicine, they said that the antibodies, which stop the SARS-CoV-2 virus from invading human cells, “declined slightly over time, as expected, but they remained elevated in all participants 3 months after the booster vaccination.”

The vaccine, called mRNA-1273, is administered in two injections given 28 days apart.

The company has been working on its American supply and production chain for months, in preparation for the vaccine’s expected emergency approval by US Food and Drug Administration (FDA).

For all countries outside the United States, production will take place in Switzerland.

US officials have said they plan to distribute 40 million vaccine doses by the end of the year, including those produced by Pfizer-BioNTech. That would mean 20 million people vaccinated by the end of 2020, with each person requiring two doses.

The Moderna vaccine will be reviewed by an advisory committee of the FDA on December 17, and could be green lit for emergency approval soon after.

The FDA advisory committee meeting for the Pfizer-BioNTech vaccine, which was approved Wednesday by Britain for general use, will take place on December 10.

FaceBook WhatsApp
 
HOME  
 
 
RELATED STORIES

Tell us what you think:

Your email address will not be published.

 

 
 
COVID vaccine, moderna coronavirus vaccine, US corona situation
 

MOST READ
MOST READ
COVID-19 vaccine updates in Pakistan and around the world
Watch: Indian pilot Abhinandan’s never seen before video
KMC moves to clear Karachi’s Orangi nullah of encroachments
Karachi water supply to be disrupted for 72 hours: KWSB
Islamabad murder: Protesters block Murree Road
Indian rooster kills owner with cockfight blade
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp